Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

5.7%

10 terminated/withdrawn out of 174 trials

Success Rate

92.6%

+6.1% vs industry average

Late-Stage Pipeline

34%

59 trials in Phase 3/4

Results Transparency

65%

82 of 126 completed trials have results

Key Signals

22 recruiting82 with results7 terminated

Enrollment Performance

Analytics

N/A

57(39.3%)

Phase 3

49(33.8%)

Phase 2

23(15.9%)

Phase 4

10(6.9%)

Phase 1

6(4.1%)

145Total

N/A(57)

Phase 3(49)

Phase 2(23)

Phase 4(10)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (174)

Showing 20 of 174 trials

NCT07518134Recruiting

A Study of Uveitis in Children <18 Years of Age

Role: lead

NCT07567833Phase 4Not Yet Recruiting

Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents

Role: lead

NCT07224321Phase 2Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Role: collaborator

NCT07061574Phase 1Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Role: collaborator

NCT05134480Not ApplicableCompleted

Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss

Role: collaborator

NCT07521475Not ApplicableNot Yet Recruiting

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Role: collaborator

NCT05589714Recruiting

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

Role: lead

NCT07270133Not Yet Recruiting

Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes

Role: lead

NCT07496515Phase 2Not Yet Recruiting

Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia

Role: lead

NCT05639556Active Not Recruiting

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Role: lead

NCT06579404Not ApplicableRecruiting

Closed-loop in Adults With Type 2 Diabetes

Role: collaborator

NCT07470164Phase 3Not Yet Recruiting

Botulinum Toxin A vs Strabismus Surgery for Esotropia

Role: lead

NCT04127006Active Not Recruiting

Rate of Progression in EYS Related Retinal Degeneration

Role: lead

NCT07095894Phase 3Not Yet Recruiting

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

Role: lead

NCT06325202Not ApplicableRecruiting

Closed Loop and Education for Hypoglycemia Awareness Restoration

Role: collaborator

NCT06449677Phase 3Recruiting

Bionic Pancreas in CFRD

Role: lead

NCT05849753Recruiting

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

Role: collaborator

NCT05785832Not ApplicableCompleted

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Role: collaborator

NCT06380517Phase 3Recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Role: lead

NCT06524882Phase 3Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Role: lead